simvastatin has been researched along with Kidney Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, FN; Chou, HC; Fann, YC; Juan, SH; Ko, TL; Lee, YG; Tung, SY | 1 |
| Jin, C; Liu, W; Qiu, Y; Wang, H; Xu, W; Zhao, Y | 1 |
| Jurida, K; Kneip, N; Marzi, I; Relja, B; Woschek, M | 1 |
| Furuya, Y; Kato, H; Koike, H; Miyao, T; Miyazawa, Y; Nitta, T; Sekine, Y; Suzuki, K | 1 |
| Abbott, L; Farah, R; Gopaluni, S; Hutchison, R; Perzova, R; Poiesz, BJ; Shrimpton, A | 1 |
1 review(s) available for simvastatin and Kidney Neoplasms
| Article | Year |
|---|---|
CD8+ cutaneous T-cell lymphoma successfully treated with bexarotene: a case report and review of the literature.
Topics: Antineoplastic Agents; Azetidines; Bexarotene; Carcinoma, Renal Cell; CD8-Positive T-Lymphocytes; Contraindications; Exanthema; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Hypothyroidism; Incidental Findings; Kidney Neoplasms; Male; Middle Aged; Mycosis Fungoides; Neoplasms, Multiple Primary; Simvastatin; Skin Neoplasms; Tetrahydronaphthalenes; Thyroxine | 2008 |
4 other study(ies) available for simvastatin and Kidney Neoplasms
| Article | Year |
|---|---|
Tumoricidal Activity of Simvastatin in Synergy with RhoA Inactivation in Antimigration of Clear Cell Renal Cell Carcinoma Cells.
Topics: Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Lipids; Mevalonic Acid; rhoA GTP-Binding Protein; Simvastatin | 2023 |
Simvastatin suppresses renal cell carcinoma cells by regulating DDX5/DUSP5.
Topics: Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; DEAD-box RNA Helicases; Dual-Specificity Phosphatases; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Simvastatin | 2021 |
Simvastatin Reduces Cancerogenic Potential of Renal Cancer Cells via Geranylgeranyl Pyrophosphate and Mevalonate Pathway.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Renal Cell; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Kidney Neoplasms; Metabolic Networks and Pathways; Mevalonic Acid; Polyisoprenyl Phosphates; Sesquiterpenes; Simvastatin; Tumor Cells, Cultured | 2016 |
YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin.
Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Inhibitor of Apoptosis Proteins; Kidney Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Naphthoquinones; RNA Interference; Simvastatin; Survivin; Time Factors; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |